NASDAQ
No price data available for this timeframe.
Corvus Pharmaceuticals, Inc. (CRVS) has a fcf yield of -5.42% as of Friday, May 29, 2026. This represents a 84.67% increase compared to its 12-month average of -35.38%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.